ABA Autism denied as not FDA-approved for this use by Molina Healthcare?

EPSDT-mandated coverage for under-21. ASD diagnosis required. Hours per BCBA-developed plan.

EPSDT 42 USC §1396d(r)(5) — Medicaid MUST cover medically necessary services for under-21 regardless of state plan limits. CASP 2020 dosage guidelines: 30-40 hrs/week for early learners. CMS Informational Bulletin July 7, 2014 on ABA under EPSDT.

## Molina Healthcare: ABA Denied as "Not FDA-Approved" — Why This Denial Is Flawed and How to Appeal

A denial of Applied Behavior Analysis (ABA) for Autism Spectrum Disorder (ASD) on the basis that it is "not FDA-approved" reflects a fundamental misunderstanding of how ABA is regulated and covered. ABA is a behavioral health therapy delivered by trained clinicians — it is not a drug or medical device subject to FDA approval. This denial type is legally and factually incorrect on its face.

### Why This Denial Happens

FDA-approval criteria apply to drugs, biologics, and medical devices. Behavioral therapies — including ABA, cognitive behavioral therapy (CBT), and other psychosocial interventions — are not regulated by the FDA and have never required FDA approval to be covered. When Molina issues this denial, it likely reflects: an administrative coding error; a policy that conflates behavioral therapy with pharmaceutical products; or a blanket exclusion for a specific ABA protocol or technology tool used in treatment that the plan has miscategorized.

Identifying the precise basis for the "not FDA-approved" classification is essential before appealing.

### Why It Is Appealable

This denial is factually incorrect as applied to ABA behavioral therapy and should be overturned at the internal appeal level. Supporting frameworks include:

• Regulatory fact: Behavioral health therapies are not FDA-regulated products. The denial category does not apply.
• ACA Section 2719 external review: If internal appeals fail, an independent clinical reviewer will almost certainly reject this classification. The external review window is approximately four months from the denial date. Expedited review is available when health is at risk.
• ERISA Section 503: Molina must disclose the specific clinical and policy basis for the denial and allow a full and fair review.
• MHPAEA: Any coverage standard applied to ABA must be no more restrictive than standards applied to comparable medical/surgical services.

### The Appeal Process

1. Request the complete denial basis in writing — ask Molina to specify exactly what it classified as "not FDA-approved" and the policy provision it relied upon. 2. Level 1 internal appeal — file within the deadline in the denial notice. Explicitly state that ABA is a behavioral health therapy, not a drug or device, and that the FDA-approval standard does not apply. 3. Level 2 internal appeal if Level 1 is not resolved. 4. External review through a certified IRO — an independent clinical reviewer will evaluate whether the denial basis is clinically and legally supportable. 5. State insurance commissioner complaint — if Molina persists, a regulatory complaint documenting the incorrect denial basis is appropriate.

### Documentation to Gather

• ASD diagnosis confirmation — formal diagnostic report.
• BCBA credentials and treatment plan — demonstrating that ABA is being delivered by a licensed behavioral health professional under an individualized clinical plan.
• Medical-necessity letter — from the treating BCBA and supervising physician.
• Clarification of denial basis — Molina's written response identifying the specific item classified as not FDA-approved.
• Regulatory clarification — if Molina's denial targets a specific technology or tool used in ABA delivery, obtain documentation of that tool's regulatory status.

### Criteria-Mapping Structure

| Molina's Denial Basis | Appeal Response | |---|---| | "Not FDA-approved" classification | [Statement that behavioral therapies are not FDA-regulated; request for Molina to identify specific item] | | ABA characterized as drug/device | [Clinical explanation of ABA as a behavioral therapy delivered by licensed clinician] | | ASD diagnosis and medical necessity | [Diagnostic report + BCBA treatment plan + physician letter] |

This appeal should be straightforward: the denial category does not apply to behavioral therapy. Document the error clearly and request immediate reconsideration.